Disease Activity and Clinical Response Early in the Course of Treatment Predict Long-Term Outcomes in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
Author(s):
Mease, P.; Fleischmann, R.; Davies, O.; Nurminen, T.; Heijde, D. van der
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Arthritis and Rheumatology (2014), Vol. 66, p. S685-S685
